Briwaracetam (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Briwaracetam" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
1st place
1st place
68th place
31st place

doi.org (Global: 2nd place; Polish: 6th place)

dx.doi.org

  • Philipp von Rosenstiel, Brivaracetam (UCB 34714), „Neurotherapeutics”, 4 (1), 2007, s. 84–87, DOI10.1016/j.nurt.2006.11.004, PMID17199019.
  • Marco Mula, Brivaracetam for the treatment of epilepsy in adults, „Expert Review of Neurotherapeutics”, 14 (4), 2014, s. 361–365, DOI10.1586/14737175.2014.896200, PMID24625006.
  • Nathalie T. Sanon, Jonathan Gagné, Daniele C. Wolf, Soumia Aboulamer, Ciprian M. Bosoi, Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model, „Epilepsy & Behavior”, 79, 2018, s. 117–125, DOI10.1016/j.yebeh.2017.11.019, PMID29287214.

europa.eu (Global: 68th place; Polish: 31st place)

ema.europa.eu

  • Briviact [online], European Medicines Agency [dostęp 2018-04-09] [zarchiwizowane z adresu 2016-06-10] (ang.).

nih.gov (Global: 4th place; Polish: 7th place)

ncbi.nlm.nih.gov

  • Philipp von Rosenstiel, Brivaracetam (UCB 34714), „Neurotherapeutics”, 4 (1), 2007, s. 84–87, DOI10.1016/j.nurt.2006.11.004, PMID17199019.
  • Marco Mula, Brivaracetam for the treatment of epilepsy in adults, „Expert Review of Neurotherapeutics”, 14 (4), 2014, s. 361–365, DOI10.1586/14737175.2014.896200, PMID24625006.
  • Nathalie T. Sanon, Jonathan Gagné, Daniele C. Wolf, Soumia Aboulamer, Ciprian M. Bosoi, Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model, „Epilepsy & Behavior”, 79, 2018, s. 117–125, DOI10.1016/j.yebeh.2017.11.019, PMID29287214.

web.archive.org (Global: 1st place; Polish: 1st place)

  • Briviact [online], European Medicines Agency [dostęp 2018-04-09] [zarchiwizowane z adresu 2016-06-10] (ang.).